Biologic drugs are precision medicines which have revolutionised the treatment of chronic diseases such as cancer and inflammatory disorders. However, there are significant manufacturing challenges in translating these therapies to the market, due to a complex, time-consuming and labour-intensive manufacturing process. Andrew Alliance S.A., the robotics company that is improving laboratory workflow execution through the […]
In January 2019 Solentim, a global leader in cell line development (CLD) instrumentation, and bioengineering company ATUM, announced a technology partnering and collaboration agreement to enable rapid, high expression, stable cell line development. But what exactly are the tangible benefits gained from both parties and for customers, and why does this fusion of technology offer more […]
VICTORIA / – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) has announced the purchase of its second state-of-the-art Intellicyt® iQue Screener PLUS for high-throughput cell-based screening. The demand for accelerated development of next-generation antibodies that recognize evermore challenging targets and have improved activities has prompted IPA to purchase further instrumentation […]
CELLINK launches new product to bring fast and sharp live-cell imaging to every incubator. Live-cell imaging is a powerful tool for ensuring successful bioprinting, but most systems are large, costly and hard to use. “One of the most important components of […]
The REPROCELL group has signed a non-exclusive distributorship agreement with RUITAI Biotechnology (Shanghai) Ltd to distribute REPROCELL’s products in China. Through the RUITAI group’s offices in Shanghai, Hangzhou, and Shenyang, and combining with existing distributors in China, the agreement aims to broaden the reach of the products of the REPROCELL group to researchers and scientists […]
First commercially available, automated single-cell analysis application to enable co-detection of cellular protein and RNA expression using microfluidics technology SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM), a leader in mass cytometry and microfluidics technologies, today announced the introduction of a REAP-seq (RNA expression and protein sequencing) protocol for use with the C1™ system. C1 REAP-seq is […]
Oxford, UK. Oxford Gene Technology (OGT), The Molecular Genetics Company, has been granted de novo classification by the US Food and Drug Administration (FDA) for eight Cytocell Aquarius®Haematology fluorescence in situ hybridisation (FISH) probes for acute myeloid leukaemia (AML) and myelodysplastic syndromes (MDS). The probes form the largest FDA-cleared in vitro diagnostic (IVD)* FISH probe range for AML and MDS on the market […]
Investment received from Greenwood Way Capital, Oxford Technology and Innovations EIS Fund and 24Haymarket Funding will be used to accelerate growth in operations and sales across the UK and USA Cambridge, UK: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, announced today that is has closed a $2 million […]
CELLINK, together with Academisch Centrum Tandheelkunde Amsterdam (ACTA), has been awarded funding for the project Functionalized Collagen-based Bioink for 3D Bioprinting –”FUNC.” The project will run for three years with a total budget of 19,5 MSEK. The project is financed to 50 percent through Eurostars. The consortium will develop a ready-to-use biofunctionalized collagen-based ink for […]
FOSS announces availability of a new Fatty Acid Origin test that helps dairy farmers to maintain desired milk fat content and composition in their milk deliveries. The test reveals changes in the fatty acid profile of raw milk that, in turn, warn of trends in milk fat that can mean lower prices for deliveries. The […]
Pay Invoice
Latest Blogs
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
